APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Montelukast API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Montelukast API Industry Growth and Trends Forecast to 2032

Report ID 174014230131 December 2025109 pages

Choose your research edition.

Industry ResearchMontelukast API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Montelukast API Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Montelukast API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Montelukast API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Montelukast API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Montelukast API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Montelukast API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Montelukast API include Merck, Mylan, Teva Pharmaceutical Industries, Sun Pharma, Sanyo Chemical Industries, Morepen Laboratories, Intas Pharmaceuticals, Delmar Chemicals and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Montelukast API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Montelukast API market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Montelukast API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Montelukast API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Montelukast API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Montelukast API Market by Company

Merck

Mylan

Teva Pharmaceutical Industries

Sun Pharma

Sanyo Chemical Industries

Morepen Laboratories

Intas Pharmaceuticals

Delmar Chemicals

Cipla

Apotex

Montelukast API Segment by Type

Chewable Tablet

Oral Solution

Tablet

Montelukast API Segment by Application

Bronchospasm

Urticaria

Asthma

Allergic Rhinitis

Others

Montelukast API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Montelukast API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Montelukast API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Montelukast API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Chewable Tablet Table 2. Major Company of Oral Solution Table 3. Major Company of Tablet Table 4. Global Montelukast API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Montelukast API Sales by Type (2021-2026) & (K Units) Table 6. Global Montelukast API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Montelukast API Sales Market Share in Value by Type (2021-2026) Table 9. Global Montelukast API Price by Type (2021-2026) & (US$/Unit) Table 10. Global Montelukast API Sales by Type (2027-2032) & (K Units) Table 11. Global Montelukast API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Montelukast API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Montelukast API Sales Market Share in Value by Type (2027-2032) Table 14. Global Montelukast API Price by Type (2027-2032) & (US$/Unit) Table 15. North America Montelukast API Sales by Type (2021-2026) & (K Units) Table 16. North America Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Montelukast API Sales by Type (2021-2026) & (K Units) Table 18. Europe Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Montelukast API Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Montelukast API Sales by Type (2021-2026) & (K Units) Table 22. Latin America Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Montelukast API Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Montelukast API Sales by Type (2021-2026) & (US$ Million) Table 25. Montelukast API Industry Trends Table 26. Montelukast API Industry Drivers Table 27. Montelukast API Industry Opportunities and Challenges Table 28. Montelukast API Industry Restraints Table 29. Global Montelukast API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Montelukast API Revenue Market Share by Company (2021-2026) Table 31. Global Montelukast API Sales by Company (2021-2026) & (K Units) Table 32. Global Montelukast API Sales Share by Company (2021-2026) Table 33. Global Montelukast API Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Montelukast API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Montelukast API Major Company Production Sites and Headquarters Table 36. Global Montelukast API Company, Product Type & Application Table 37. Global Montelukast API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Montelukast API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Montelukast API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Montelukast API Sales by Region (2021-2026) & (K Units) Table 42. Global Montelukast API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Montelukast API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Montelukast API Sales Market Share in Value by Region (2021-2026) Table 45. Global Montelukast API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Montelukast API Sales by Region (2027-2032) & (K Units) Table 47. Global Montelukast API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Montelukast API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Montelukast API Sales Market Share in Value by Region (2027-2032) Table 50. Global Montelukast API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Montelukast API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Montelukast API Sales by Application (2021-2026) & (K Units) Table 53. Global Montelukast API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Montelukast API Sales Market Share in Value by Application (2021-2026) Table 56. Global Montelukast API Price by Application (2021-2026) & (US$/Unit) Table 57. Global Montelukast API Sales by Application (2027-2032) & (K Units) Table 58. Global Montelukast API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Montelukast API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Montelukast API Sales Market Share in Value by Application (2027-2032) Table 61. Global Montelukast API Price by Application (2027-2032) & (US$/Unit) Table 62. North America Montelukast API Sales by Application (2021-2026) & (K Units) Table 63. North America Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Montelukast API Sales by Application (2021-2026) & (K Units) Table 65. Europe Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Montelukast API Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Montelukast API Sales by Application (2021-2026) & (K Units) Table 69. Latin America Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Montelukast API Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Montelukast API Sales by Application (2021-2026) & (US$ Million) Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Merck Montelukast API Product Portfolio Table 76. Merck Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Mylan Montelukast API Product Portfolio Table 81. Mylan Recent Development Table 82. Teva Pharmaceutical Industries Company Information Table 83. Teva Pharmaceutical Industries Business Overview Table 84. Teva Pharmaceutical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Teva Pharmaceutical Industries Montelukast API Product Portfolio Table 86. Teva Pharmaceutical Industries Recent Development Table 87. Sun Pharma Company Information Table 88. Sun Pharma Business Overview Table 89. Sun Pharma Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sun Pharma Montelukast API Product Portfolio Table 91. Sun Pharma Recent Development Table 92. Sanyo Chemical Industries Company Information Table 93. Sanyo Chemical Industries Business Overview Table 94. Sanyo Chemical Industries Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanyo Chemical Industries Montelukast API Product Portfolio Table 96. Sanyo Chemical Industries Recent Development Table 97. Morepen Laboratories Company Information Table 98. Morepen Laboratories Business Overview Table 99. Morepen Laboratories Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Morepen Laboratories Montelukast API Product Portfolio Table 101. Morepen Laboratories Recent Development Table 102. Intas Pharmaceuticals Company Information Table 103. Intas Pharmaceuticals Business Overview Table 104. Intas Pharmaceuticals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Intas Pharmaceuticals Montelukast API Product Portfolio Table 106. Intas Pharmaceuticals Recent Development Table 107. Delmar Chemicals Company Information Table 108. Delmar Chemicals Business Overview Table 109. Delmar Chemicals Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Delmar Chemicals Montelukast API Product Portfolio Table 111. Delmar Chemicals Recent Development Table 112. Cipla Company Information Table 113. Cipla Business Overview Table 114. Cipla Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Cipla Montelukast API Product Portfolio Table 116. Cipla Recent Development Table 117. Apotex Company Information Table 118. Apotex Business Overview Table 119. Apotex Montelukast API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Apotex Montelukast API Product Portfolio Table 121. Apotex Recent Development Table 122. North America Montelukast API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Montelukast API Sales by Country (2021-2026) & (K Units) Table 124. North America Montelukast API Sales Market Share by Country (2021-2026) Table 125. North America Montelukast API Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Montelukast API Sales Market Share Forecast by Country (2027-2032) Table 127. North America Montelukast API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Montelukast API Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Montelukast API Market Share by Country (2021-2026) Table 130. North America Montelukast API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Montelukast API Market Share Forecast by Country (2027-2032) Table 132. Europe Montelukast API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Montelukast API Sales by Country (2021-2026) & (K Units) Table 134. Europe Montelukast API Sales Market Share by Country (2021-2026) Table 135. Europe Montelukast API Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Montelukast API Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Montelukast API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Montelukast API Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Montelukast API Market Share by Country (2021-2026) Table 140. Europe Montelukast API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Montelukast API Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Montelukast API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Montelukast API Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Montelukast API Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Montelukast API Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Montelukast API Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Montelukast API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Montelukast API Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Montelukast API Market Share by Country (2021-2026) Table 150. Asia-Pacific Montelukast API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Montelukast API Market Share Forecast by Country (2027-2032) Table 152. Latin America Montelukast API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Montelukast API Sales by Country (2021-2026) & (K Units) Table 154. Latin America Montelukast API Sales Market Share by Country (2021-2026) Table 155. Latin America Montelukast API Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Montelukast API Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Montelukast API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Montelukast API Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Montelukast API Market Share by Country (2021-2026) Table 160. Latin America Montelukast API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Montelukast API Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Montelukast API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Montelukast API Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Montelukast API Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Montelukast API Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Montelukast API Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Montelukast API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Montelukast API Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Montelukast API Market Share by Country (2021-2026) Table 170. Middle East and Africa Montelukast API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Montelukast API Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Montelukast API Distributors List Table 175. Montelukast API Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Montelukast API Image Figure 2. Global Montelukast API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Montelukast API Market Size (2021-2032) & (US$ Million) Figure 4. Global Montelukast API Sales (2021-2032) & (K Units) Figure 5. Chewable Tablet Image Figure 6. Global Chewable Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tablet Image Figure 10. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Montelukast API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Montelukast API Market Share by Type 2025 VS 2032 Figure 13. North America Montelukast API Sales Market Share in Volume by Type in 2025 Figure 14. North America Montelukast API Sales Market Share in Value by Type in 2025 Figure 15. Europe Montelukast API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Montelukast API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Montelukast API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Montelukast API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Montelukast API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Montelukast API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Montelukast API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Montelukast API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Montelukast API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Bronchospasm Image Figure 26. Global Bronchospasm Sales YoY Growth (2021-2032) & (K Units) Figure 27. Urticaria Image Figure 28. Global Urticaria Sales YoY Growth (2021-2032) & (K Units) Figure 29. Asthma Image Figure 30. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Allergic Rhinitis Image Figure 32. Global Allergic Rhinitis Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Montelukast API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Montelukast API Market Share by Application 2025 VS 2032 Figure 37. North America Montelukast API Sales Market Share in Volume by Application in 2025 Figure 38. North America Montelukast API Sales Market Share in Value by Application in 2025 Figure 39. Europe Montelukast API Sales Market Share in Volume by Application in 2025 Figure 40. Europe Montelukast API Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Montelukast API Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Montelukast API Sales Market Share in Value by Application in 2025 Figure 43. Latin America Montelukast API Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Montelukast API Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Montelukast API Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Montelukast API Sales Market Share in Value by Application in 2025 Figure 47. North America Montelukast API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Montelukast API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Montelukast API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Montelukast API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Montelukast API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Montelukast API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Montelukast API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Montelukast API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Montelukast API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Montelukast API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Montelukast API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Montelukast API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Montelukast API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Montelukast API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Montelukast API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Montelukast API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Montelukast API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Montelukast API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Montelukast API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Montelukast API Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Montelukast API Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Montelukast API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Chewable Tablet
  • Oral Solution
  • Tablet
Applications
  • Bronchospasm
  • Urticaria
  • Asthma
  • Allergic Rhinitis
  • Others
Companies covered
  • Merck
  • Mylan
  • Teva Pharmaceutical Industries
  • Sun Pharma
  • Sanyo Chemical Industries
  • Morepen Laboratories
  • Intas Pharmaceuticals
  • Delmar Chemicals
  • Cipla
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Montelukast API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Montelukast API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Montelukast API Market by Type
  6. 1.3.1 Chewable Tablet
  7. 1.3.2 Oral Solution
  8. 1.3.3 Tablet
  9. 1.4 Global Montelukast API Market Size by Type
  10. 1.4.1 Global Montelukast API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Montelukast API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Montelukast API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Montelukast API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Montelukast API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Montelukast API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Montelukast API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Montelukast API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Montelukast API Industry Trends
  2. 2.2 Montelukast API Industry Drivers
  3. 2.3 Montelukast API Industry Opportunities and Challenges
  4. 2.4 Montelukast API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Montelukast API Revenue (2021-2026)
  2. 3.2 Global Top Players by Montelukast API Sales (2021-2026)
  3. 3.3 Global Top Players by Montelukast API Price (2021-2026)
  4. 3.4 Global Montelukast API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Montelukast API Major Company Production Sites & Headquarters
  6. 3.6 Global Montelukast API Company, Product Type & Application
  7. 3.7 Global Montelukast API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Montelukast API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Montelukast API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Montelukast API Tier 1, Tier 2, and Tier 3
4 Montelukast API Regional Status and Outlook
  1. 4.1 Global Montelukast API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Montelukast API Historic Market Size by Region
  3. 4.2.1 Global Montelukast API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Montelukast API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Montelukast API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Montelukast API Forecasted Market Size by Region
  7. 4.3.1 Global Montelukast API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Montelukast API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Montelukast API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Montelukast API by Application
  1. 5.1 Montelukast API Market by Application
  2. 5.1.1 Bronchospasm
  3. 5.1.2 Urticaria
  4. 5.1.3 Asthma
  5. 5.1.4 Allergic Rhinitis
  6. 5.1.5 Others
  7. 5.2 Global Montelukast API Market Size by Application
  8. 5.2.1 Global Montelukast API Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Montelukast API Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Montelukast API Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Montelukast API Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Montelukast API Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Montelukast API Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Montelukast API Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Montelukast API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Montelukast API Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Montelukast API Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Teva Pharmaceutical Industries
  14. 6.3.1 Teva Pharmaceutical Industries Company Information
  15. 6.3.2 Teva Pharmaceutical Industries Business Overview
  16. 6.3.3 Teva Pharmaceutical Industries Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Pharmaceutical Industries Montelukast API Product Portfolio
  18. 6.3.5 Teva Pharmaceutical Industries Recent Developments
  19. 6.4 Sun Pharma
  20. 6.4.1 Sun Pharma Company Information
  21. 6.4.2 Sun Pharma Business Overview
  22. 6.4.3 Sun Pharma Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharma Montelukast API Product Portfolio
  24. 6.4.5 Sun Pharma Recent Developments
  25. 6.5 Sanyo Chemical Industries
  26. 6.5.1 Sanyo Chemical Industries Company Information
  27. 6.5.2 Sanyo Chemical Industries Business Overview
  28. 6.5.3 Sanyo Chemical Industries Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanyo Chemical Industries Montelukast API Product Portfolio
  30. 6.5.5 Sanyo Chemical Industries Recent Developments
  31. 6.6 Morepen Laboratories
  32. 6.6.1 Morepen Laboratories Company Information
  33. 6.6.2 Morepen Laboratories Business Overview
  34. 6.6.3 Morepen Laboratories Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Morepen Laboratories Montelukast API Product Portfolio
  36. 6.6.5 Morepen Laboratories Recent Developments
  37. 6.7 Intas Pharmaceuticals
  38. 6.7.1 Intas Pharmaceuticals Company Information
  39. 6.7.2 Intas Pharmaceuticals Business Overview
  40. 6.7.3 Intas Pharmaceuticals Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Intas Pharmaceuticals Montelukast API Product Portfolio
  42. 6.7.5 Intas Pharmaceuticals Recent Developments
  43. 6.8 Delmar Chemicals
  44. 6.8.1 Delmar Chemicals Company Information
  45. 6.8.2 Delmar Chemicals Business Overview
  46. 6.8.3 Delmar Chemicals Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Delmar Chemicals Montelukast API Product Portfolio
  48. 6.8.5 Delmar Chemicals Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Montelukast API Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 Apotex
  56. 6.10.1 Apotex Company Information
  57. 6.10.2 Apotex Business Overview
  58. 6.10.3 Apotex Montelukast API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Apotex Montelukast API Product Portfolio
  60. 6.10.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Montelukast API Sales by Country
  2. 7.1.1 North America Montelukast API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Montelukast API Sales by Country (2021-2026)
  4. 7.1.3 North America Montelukast API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Montelukast API Market Size by Country
  6. 7.2.1 North America Montelukast API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Montelukast API Market Size by Country (2021-2026)
  8. 7.2.3 North America Montelukast API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Montelukast API Sales by Country
  2. 8.1.1 Europe Montelukast API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Montelukast API Sales by Country (2021-2026)
  4. 8.1.3 Europe Montelukast API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Montelukast API Market Size by Country
  6. 8.2.1 Europe Montelukast API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Montelukast API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Montelukast API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Montelukast API Sales by Country
  2. 9.1.1 Asia-Pacific Montelukast API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Montelukast API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Montelukast API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Montelukast API Market Size by Country
  6. 9.2.1 Asia-Pacific Montelukast API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Montelukast API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Montelukast API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Montelukast API Sales by Country
  2. 10.1.1 South America Montelukast API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Montelukast API Sales by Country (2021-2026)
  4. 10.1.3 South America Montelukast API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Montelukast API Market Size by Country
  6. 10.2.1 South America Montelukast API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Montelukast API Market Size by Country (2021-2026)
  8. 10.2.3 South America Montelukast API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Montelukast API Sales by Country
  2. 11.1.1 Middle East and Africa Montelukast API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Montelukast API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Montelukast API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Montelukast API Market Size by Country
  6. 11.2.1 Middle East and Africa Montelukast API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Montelukast API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Montelukast API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Montelukast API Value Chain Analysis
  2. 12.1.1 Montelukast API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Montelukast API Production Mode & Process
  7. 12.2 Montelukast API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Montelukast API Distributors
  10. 12.2.3 Montelukast API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst